Glenmede Trust Company »

Alpine Immune Sciences shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $229k 5.8k 39.64

More positions owned by Glenmede Trust Company

Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds Small Cp Etf (VB)
Home Depot (HD)
Procter & Gamble Company (PG)
Accenture Plc Ireland Shs Class A (ACN)

View all positions for Glenmede Trust Company

Top funds holding Alpine Immune Sciences

Decheng Capital
venBio Select Advisor
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
State Street Corporation
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management

View all funds holding Alpine Immune Sciences